Literature DB >> 8665182

Molecular genetic basis of colorectal cancer susceptibility.

C Cunningham1, M G Dunlop.   

Abstract

The past decade has seen considerable advances in understanding of the molecular processes involved in the development of colorectal cancer. With an increased awareness of genetic aspects of the disease there have already been significant changes in clinical management. This is exemplified by familial adenomatous polyposis, where identification of mutations in the adenomatous polyposis coli (APC) gene in affected individuals can be used directly to reduce the requirement for clinical screening in at-risk relatives. In other more common but less well defined heritable forms of colorectal cancer, testing to identify individuals for early diagnosis and treatment will soon become routine practice. This review does not set out to discuss all aspects of the molecular genetics of colorectal cancer but concentrates on the roles of the APC gene and the recently discovered DNA mismatch repair genes in colorectal cancer. The identification of these genes and their functional significance in the neoplastic process is discussed, and the relevance of such discoveries to future research and clinical management explored.

Entities:  

Mesh:

Year:  1996        PMID: 8665182     DOI: 10.1002/bjs.1800830309

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

Review 1.  Genetic diversity and disease susceptibility.

Authors:  W F Bodmer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-08-29       Impact factor: 6.237

2.  Role of detection of microsatellite instability in Chinese with hereditary nonpolyposis colorectal cancer or ordinary hereditary colorectal cancer.

Authors:  Wen-Zhi Liu; Feng Jin; Zhen-Hai Zhang; Shu-Bao Wang
Journal:  World J Gastroenterol       Date:  2006-08-07       Impact factor: 5.742

3.  Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis.

Authors:  M P de Leon; M Pedroni; P Benatti; A Percesepe; C Di Gregorio; M Foroni; G Rossi; M Genuardi; G Neri; F Leonardi; A Viel; E Capozzi; M Boiocchi; L Roncucci
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

4.  Elevated levels of the pro-carcinogenic adduct, O(6)-methylguanine, in normal DNA from the cancer prone regions of the large bowel.

Authors:  A C Povey; C N Hall; A F Badawi; D P Cooper; P J O'Connor
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

5.  Purification of total RNA from human stool samples.

Authors:  R J Alexander; R F Raicht
Journal:  Dig Dis Sci       Date:  1998-12       Impact factor: 3.199

6.  Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.

Authors:  Fáblio Oliveira Ferreira; Claudia Cristina Napoli Ferreira; Benedito Mauro Rossi; Wilson Toshihiko Nakagawa; Samuel Aguilar; Erika Maria Monteiro Santos; Marcelo Leite Vierira Costa; Ademar Lopes
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 7.  Screening for colorectal cancer.

Authors:  W J Campbell; R J Moorehead
Journal:  Ulster Med J       Date:  1997-05

8.  Are there socio-economic inequalities in age of resection of colorectal cancer in people with HNPCC?

Authors:  Jean Adams; Martin White; Gail Barker; John Mathers; John Burn
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.446

9.  Repurposing the FDA-approved pinworm drug pyrvinium as a novel chemotherapeutic agent for intestinal polyposis.

Authors:  Bin Li; Colin A Flaveny; Camilla Giambelli; Dennis Liang Fei; Lu Han; Brian I Hang; Feng Bai; Xin-Hai Pei; Vania Nose; Oname Burlingame; Anthony J Capobianco; Darren Orton; Ethan Lee; David J Robbins
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.